Abstract:Background: Lung cancer is the most prevalent type of cancer and the leading cause of cancer-related death. Chemotherapic resistance is one of the most prominent obstacles to treating lung cancer patients. Skp2 is upregulated, accompanied by the downregulation of MLKL and contributes to cisplatin resistance in NSCLC. We investigated the mechanism underlying the aberrant Skp2 linked to cisplatin resistance in NSCLC. Methods: We confirmed Skp2 and MLKL interaction by co-immunoprecipitation assays. We analyzed the biologic consequences of knockdown or overexpression of Skp2 using immunoblotting, immunoprecipitation, and immunohistochemistry. We analyzed Skp2-regulated MLKL degradation by ubiquitination assays. We tested the functions of Skp2, Skp2-ubiquitinated MLKL degradation and NSCLC chemoresistance by measuring cell viability, anchorage-independent cell growth, and mouse xenograft tumorigenesis. Results: Skp2 is overexpressed, accompanied by the downregulation of MLKL in human NSCLC tissues and cell lines. Knockdown of Skp2 inhibited cell viability, colony formation, and xenograft tumor growth. We demonstrated that Skp2 interacted with MLKL and promoted the ubiquitination and degradation of MLKL in NSCLC cell lines. Notably, Skp2 was highly expressed in cisplatin-resistant NSCLC cells and negatively correlated with MLKL. Furthermore, the silence of Skp2 partially restored MLKL and sensitized NSCLC cells to cisplatin. Interpretation: Our results suggest that the inhibition of Skp2-regulated MLKL ubiquitination may overcome NSCLC chemoresistance.Funding: This work was supported by the National Natural Science Foundation of China (No. 82073260, 81972837, 82003203, 81572280, 81401548) and the Natural Science Foundation of Hunan Province (No. 2021JJ31011, 2021JJ41058).Declaration of Interest: The authors have declared no conflicts of interest.Ethical Approval: This study was approved by the Ethics Committee of the Second Xiangya Hospital or the Ethics Committee of Xiangya Hospital, Central South University, China. All the patients provided their written informed consent. The animal experiments were approved by the Medical Research Animal Ethics Committee, Central South University, China.

SCML2 Contributes to Tumor Cell Resistance to DNA Damage Through Regulating P53 and CHK1 Stability

Targeting Mouse Double Minute 2: Current Concepts in DNA Damage Repair and Therapeutic Approaches in Cancer.

USP37 Regulates DNA Damage Response Through Stabilizing and Deubiquitinating BLM

Skp2-mediated MLKL degradation confers cisplatin-resistant in non-small cell lung cancer cells

Skp2-Ubiquitinated MLKL Degradation Confers Cisplatin-Resistant in NSCLC Cells

USP39 Regulates DNA Damage Response and Chemo-Radiation Resistance by Deubiquitinating and Stabilizing CHK2.

Skp2 Stabilizes Mcl-1 and Confers Radioresistance in Colorectal Cancer

CDYL promotes the chemoresistance of small cell lung cancer by regulating H3K27 trimethylation at the CDKN1C promoter

MLF2 Negatively Regulates P53 and Promotes Colorectal Carcinogenesis

A CANCER PERSISTENT DNA REPAIR CIRCUIT DRIVEN BY MDM2, MDM4 (MDMX), AND MUTANT P53 FOR RECRUITMENT OF MDC1 AND 53BP1 TO CHROMATIN

Phosphorylation by casein kinase I promotes the turnover of the Mdm2 oncoprotein via the SCF(beta-TRCP) ubiquitin ligase.

MICAL2 Mediates P53 Ubiquitin Degradation Through Oxidating P53 Methionine 40 and 160 and Promotes Colorectal Cancer Malignance

P53 Deficiency-Induced Smad1 Upregulation Suppresses Tumorigenesis and Causes Chemoresistance in Colorectal Cancers.

Inhibition of expression of the chromatin remodeling gene, SNF2L, selectively leads to DNA damage, growth inhibition, and cancer cell death.

PML Recruits TET2 to Regulate DNA Modification and Cell Proliferation in Response to Chemotherapeutic Agent.

USP25 Elevates SHLD2‐Mediated DNA Double‐Strand Break Repair and Regulates Chemoresponse in Cancer

p53 Affects PGC1α Stability Through AKT/GSK-3β to Enhance Cisplatin Sensitivity in Non-Small Cell Lung Cancer

Phosphorylation by Casein Kinase I Promotes the Turnover of the Mdm2 Oncoprotein via the SCFβ-TRCP Ubiquitin Ligase

The MutSβ complex is a modulator of p53-driven tumorigenesis through its functions in both DNA double-strand break repair and mismatch repair

Silencing of Proteasome 26S Subunit ATPase 2 Regulates Colorectal Cancer Cell Proliferation, Apoptosis, and Migration

USP3 promotes DNA damage response and chemotherapy resistance through stabilizing and deubiquitinating SMARCA5 in prostate cancer